Tech Company Financing Transactions
OTR Therapeutics Funding Round
OTR Therapeutics, based in Shanghai, secured $100 million from LAV Fund, Pfizer Venture Investments and Sirona Capital.
Transaction Overview
Company Name
Announced On
12/8/2025
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to advance its pipeline of differentiated programs that target significant treatment gaps in immunology and inflammation, oncology, and other disease areas.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Building 2, No. 2966 Jinke Road, Pudong New Area
Shanghai, Undisclosed
China
Shanghai, Undisclosed
China
Phone
Undisclosed
Website
Email Address
Overview
Mission: To catalyze early innovation to deliver life-changing medicines globally to patients through unparalleled R&D efficiency and agile partnerships. We define the success of our work at OTR Therapeutics by the impact we make for our patients, partners and employees.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Co-Founder
Zhui Chen
Co-Founder
Shannon Chuai
Co-Founder
Yuan Shi
Browse more venture capital transactions:
Prev: 12/8/2025: Digital Asset venture capital transaction
Next: 12/8/2025: Airwallex venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs